These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6981456)

  • 41. The pathogenesis of venous thromboembolism.
    Girolami A; Prandoni P; Simioni P; Girolami B; Scarano L; Zanon E
    Haematologica; 1995; 80(2 Suppl):25-35. PubMed ID: 7628768
    [No Abstract]   [Full Text] [Related]  

  • 42. Venous thromboembolism and cancer.
    Sander RW; Flynn CA
    J Fam Pract; 1998 Jul; 47(1):13-4. PubMed ID: 9673599
    [No Abstract]   [Full Text] [Related]  

  • 43. Serum alpha one antitrypsin in malignancy.
    Yemul VL; Kumthekar SN; Muley PR; Agrawal BR
    Indian J Cancer; 1987 Jun; 24(2):107-11. PubMed ID: 3500907
    [No Abstract]   [Full Text] [Related]  

  • 44. [Immunochemical determination of alpha 1-antitrypsin in liver diseases].
    Heidl G; Kunze KD
    Acta Histochem Suppl; 1984; 30():215-9. PubMed ID: 6425941
    [No Abstract]   [Full Text] [Related]  

  • 45. D-dimer testing and recurrent venous thromboembolism after unprovoked pulmonary embolism: A post-hoc analysis of the prolong extension study.
    Pengo V; Palareti G; Cosmi B; Legnani C; Tosetto A; Alatri A; Marzot F; Pegoraro C; Cucchini U; Iliceto S;
    Thromb Haemost; 2008 Oct; 100(4):718-21. PubMed ID: 18841301
    [No Abstract]   [Full Text] [Related]  

  • 46. [Importance of the quantitative analysis of alpha 1-antitrypsin in respiratory pathology].
    Macquet V; Ficheroulle X; Gentillini JL; Mehadji A
    LARC Med; 1981 Oct; 1(1):43-5. PubMed ID: 6984478
    [No Abstract]   [Full Text] [Related]  

  • 47. Deep venous thrombosis and pulmonary embolism after knee arthroscopy in athletes carrying the thrombophilic factor lupus anticoagulant.
    Pola E; Flex A; Papaleo P; Gaetani E; Delcogliano A; Pola P
    Arthroscopy; 2005 Jan; 21(1):103-7. PubMed ID: 15650675
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A19 A29 B, and O blood-groups, Lewis blood-groups, and serum triglyceride and cholesterol concentrations in patients with venous thromboembolic disease.
    Talbot S; Wakley EJ; Langman MJ
    Lancet; 1972 May; 1(7761):1152-4. PubMed ID: 4113058
    [No Abstract]   [Full Text] [Related]  

  • 49. Serial estimation of alpha-1-antitrypsin in active pulmonary tuberculosis.
    Chawhan RN; Mehta SM; Sengupta SR; Zawar PB
    Indian J Med Res; 1984 Feb; 79():187-90. PubMed ID: 6430795
    [No Abstract]   [Full Text] [Related]  

  • 50. [Alpha 1-antitrypsin content in bronchial asthma patients undergoing immunosuppressive therapy].
    Rudyk BI; Baranovskiĭ PV
    Vrach Delo; 1982 Feb; (2):99-101. PubMed ID: 6977946
    [No Abstract]   [Full Text] [Related]  

  • 51. [Evaluation of the elastase burden in patients with idiopathic interstitial pneumonia].
    Kamei T; Fujita J; Yamaji Y; Takahara J
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Sep; 31(9):1081-8. PubMed ID: 8255016
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 'Idiopathic' venous thrombosis and alpha 1-antitrypsin excess.
    Franz RC
    S Afr Med J; 1980 Jul; 58(4):149-50. PubMed ID: 6967629
    [No Abstract]   [Full Text] [Related]  

  • 53. A new electrophoretic variant of fibrinogen associated with venous thromboembolism, fibrinogen Bordeaux Aalpha Arg439-->Cys.
    Hanss M; Vergnes C; Rugeri L; Ffrench P; DE Mazancourt P
    J Thromb Haemost; 2008 Aug; 6(8):1422-4. PubMed ID: 18485090
    [No Abstract]   [Full Text] [Related]  

  • 54. Risk factor profiles in patients with different clinical manifestations of venous thromboembolism: a focus on the factor V Leiden mutation.
    Manten B; Westendorp RG; Koster T; Reitsma PH; Rosendaal FR
    Thromb Haemost; 1996 Oct; 76(4):510-3. PubMed ID: 8902987
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Alpha1-antitrypsin].
    Nukiwa T
    Nihon Rinsho; 2004 Nov; 62 Suppl 11():262-5. PubMed ID: 15628390
    [No Abstract]   [Full Text] [Related]  

  • 56. [Initial personal experiences with alpha-1-antitrypsin determination in feces].
    Schwery S; Meyenberger C; Ammann R; Wirth HP
    Schweiz Med Wochenschr; 1995 Sep; 125(38):1783-7. PubMed ID: 7481635
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Incidence of venous thromboembolism in patients hospitalized with cancer.
    Stein PD; Beemath A; Meyers FA; Skaf E; Sanchez J; Olson RE
    Am J Med; 2006 Jan; 119(1):60-8. PubMed ID: 16431186
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Behavior of alpha-1-antitrypsin in renal polycystic disease].
    Pintacuda S; Di Blasi S; Amato S; Monastero R
    Boll Soc Ital Biol Sper; 1974 Nov; 50(22):1963-5. PubMed ID: 4549345
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of variation in alpha-1-antritrypsin phenotype upon incidence of respiratory illness in an unselected working population.
    Cole RB; Nevin NC; Bradley BL; Blundell G
    Proc R Soc Med; 1976 Feb; 69(2):132-3. PubMed ID: 1083530
    [No Abstract]   [Full Text] [Related]  

  • 60. Venous macrothromboembolism in an unselected autopsy material and its relation to antiplasmin activity in the vessel wall.
    Eriksson M; Saldeen T
    Thromb Res; 1980 Dec 1-15; 20(5-6):555-61. PubMed ID: 6453433
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.